Does the coronavirus merit investment, or personal, concern or consideration?

This guy has been giving the establishment a hard time about their vaccine policy for a while. He’s more down on some of the vaccines, but definitely is on the money for his policy comments.

——

I have been deeply involved in multiple prior outbreak responses including AIDS, the Post Anthrax/Smallpox scare, Pandemic Influenza, Ebola, Zika, and now SARS-CoV-2.

Prior to SARS-CoV-2, the teaching and practice in governmental response has been that the federal Centers for Disease Control and Prevention (CDC) advises state public health authorities, who have the authority and responsibility (based on U.S. Constitution) to manage their own public health policies and regulate the practice of medicine.

During prior outbreaks, CDC served as a reliable source of impartial, up to date and accurate public health data for physicians, state and local public health officers.

In my professional experience, during all prior outbreaks and vaccine development programs, risks and benefits have always been evaluated and stratified by risk group, and public health recommendations have been tailored to account for differences in risk/benefit ratios (often adjusted based on actuarial “quality adjusted life year” calculus).

This approach has not been implemented curing the COVID crisis. During the SARS-CoV-2/COVID-19 outbreak, new policies and practices have been implemented.

The NIH (and particularly) NIAID have developed and propagated treatment protocols throughout the United States. These protocols have been developed in a non-transparent manner without hearings or significant public comment or independent practicing physician input, apparently largely under the strong influence and oversight of a small number of government officials (predominantly Dr. Anthony Fauci and his former trainee Dr. Deborah Birx).

Development of vaccine products has been accelerated and historic non-clinical, clinical development and regulatory practices have been discarded in a quest for speed under specific pressure from the executive branch.

Development of repurposed drugs and treatment strategies have paradoxically been aggressively blocked or inhibited by both NIH and FDA, apparently due to requirements in the federal Emergency Use Authorization statute language requiring lack of available alternatives as a predicate to granting EUA to a new (vaccine) product.

The CDC has played a more supportive role to NIH, in contrast to prior where NIH/NIAID has focused on clinical research and early product development, and CDC focused on public health policy.

CDC has become politicized, particularly during the current administration, and has actively withheld information which has been deemed as posing risk for exacerbating “vaccine hesitancy”.

During the current outbreak, CDC has not fulfilled its traditional role as a neutral collector, arbiter and reporter of public health data. CDC has, under FOIA, admitted to failing to perform obligated monitoring, analysis and reporting of VAERS and related vaccine safety data. As a consequence, neither patients, physicians, nor public health officials have been able to access up-to-date information concerning vaccine effectiveness and safety. This has compromised the informed consent process.

CDC has actively promoted and marketed vaccination with unlicensed (emergency use authorized) products, with over $1 Billion USD in federal funding expended to both market the products and to censor those who have raised concerns regarding vaccine safety and effectiveness

FDA, NIH, and CDC (together with WHO) have cooperated to actively restrict, demean, and deprecate use of multiple currently available licensed drugs for treatment of COVID-19 by licensed practicing physicians, and have facilitated retaliation against physicians who do not follow the treatment guidelines established and promoted by the NIH – which has neither mandate nor significant prior experience in developing and implementing universal treatment guidance and protocols, and which has done so in a unilateral manner without seeking meaningful input from practicing physicians.

NIH leadership have acted to restrict and retaliate against highly qualified, independent physicians and medical scientists who have questioned federal management policies, most notably in the case of the Great Barrington Declaration and the primary authors of that document.

On a national basis, without respect for state boundaries or coordination with state governments, NIH and CDC have actively engaged with and directly paid corporate media and technology/social media companies to promote federal positions and policies, and to censor any discussions of policies, risks, adverse events, or treatment options other than those which they have endorsed.

There is evidence, in the case of the State of Florida and Governor Ron Desantis, that the Federal Government has intentionally withheld monoclonal antibody therapeutics as political retaliation for COVID crisis management policies implemented by the State of Florida, which are not aligned with Federal Government policies and mandates.

—-

I’m less sure about his comments on immunological imprinting causing vaccine effectiveness issues.

3 Likes